|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0200 USD | -2.44% |
|
-11.89% | -67.43% |
| 06-03 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.08M 3.57M 3.29M 3.03M 5.72M 393M 5.84M 39.32M 15.47M 192M 15.32M 14.98M 662M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.8M 5.07M 4.68M 4.31M 8.12M 558M 8.3M 55.88M 21.98M 273M 21.77M 21.29M 941M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | -2.44% | ||
| 1 week | -11.89% | ||
| Current month | -17.70% | ||
| 3 months | -34.43% | ||
| 6 months | -57.17% | ||
| Current year | -67.43% |
| 1 week | 0.02 | 0.02 | |
| 1 month | 0.02 | 0.03 | |
| Current year | 0.02 | 0.1 | |
| 1 year | 0.02 | 0.1 | |
| 3 years | 0.02 | 0.1 | |
| 5 years | 0.02 | 0.36 | |
| 10 years | 0.02 | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/2/25 | Free | Director | 500,000 | 0.2714% | ||
| 18/2/25 | Free | Chief Financial Officer | 2,350,000 | 1.2753% | ||
| 18/2/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.44% | -11.89% | -45.21% | -55.75% | 4.08M | ||
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | ||
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | ||
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | ||
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | ||
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | ||
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | ||
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | ||
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | ||
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | ||
| Average | -0.31% | -0.70% | +21.16% | +42.94% | 357.51B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.72M 12.66M 11.67M 22M 1.51B 22.49M 151M 59.54M 741M 58.98M 57.69M 2.55B | 13.79M 12.05M 11.12M 10.25M 19.32M 1.33B 19.75M 133M 52.28M 650M 51.78M 50.65M 2.24B |
| Net income | -2.39M -2.09M -1.93M -1.78M -3.35M -231M -3.43M -23.07M -9.08M -113M -8.99M -8.79M -389M | -958K -837K -773K -712K -1.34M -92.26M -1.37M -9.23M -3.63M -45.18M -3.6M -3.52M -156M |
| Net Debt | 325K 284K 262K 242K 455K 31.3M 465K 3.13M 1.23M 15.33M 1.22M 1.19M 52.77M | 1.72M 1.5M 1.39M 1.28M 2.41M 165M 2.46M 16.56M 6.51M 81.03M 6.45M 6.31M 279M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | US$0.0200 | -2.44% | 1,039,549 |
| 16/07/26 | US$0.0205 | +6.99% | 262,469 |
| 15/07/26 | US$0.0192 | -9.41% | 126,569 |
| 14/07/26 | US$0.0212 | -4.08% | 126,820 |
| 13/07/26 | US$0.0221 | -2.78% | 221,838 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















